Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Single Dose Intranasal Insulin on Cognitive Function in Patients With Schizophrenia

NCT00646581 is registered in ClinicalTrials.gov with University of Massachusetts, Worcester as lead sponsor.

NCT NCT00646581
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00646581 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Single Dose Intranasal Insulin on Cognitive Function in Patients With Schizophrenia
Lead sponsor
University of Massachusetts, Worcester
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2006
Completion date
January 31, 2010
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizoaffective disorder, schizophrenia